STOCK TITAN

Schrödinger to Announce Third Quarter 2022 Financial Results on November 3

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Schrödinger (Nasdaq: SDGR) will release its third quarter 2022 financial results on November 3, 2022, after market close, followed by a conference call at 4:30 p.m. ET. Participants can access the live webcast through the company’s investor website. Schrödinger is focused on transforming therapeutics and materials discovery via its physics-based computational platform, which speeds up molecule discovery for drug development and materials applications while reducing costs. Established in 1990, the company operates globally with over 700 employees.

Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2022 financial results on Thursday, November 3, 2022, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed under "News & Events" in the investors section of Schrödinger’s website, https://ir.schrodinger.com/news-and-events/event-calendar. To participate in the live call, please register for the call here. It is recommended that participants register at least 15 minutes in advance of the call. Once registered, participants will receive the dial-in information. The archived webcast will be available on Schrödinger’s website for approximately 90 days following the event.

About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has over 700 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn, Twitter and Instagram, or visit our blog, Extrapolations.com.

Jaren Irene Madden (Investors)

Schrödinger, Inc.

jaren.madden@schrodinger.com

617-286-6264



Tracy Lessor (Media)

Schrödinger, Inc.

tracy.lessor@schrodinger.com

617-519-9827

Source: Schrödinger

FAQ

When will Schrödinger report its financial results for Q3 2022?

Schrödinger will report its financial results for Q3 2022 on November 3, 2022.

What time is the conference call for Schrödinger's Q3 2022 results?

The conference call for Schrödinger's Q3 2022 results is scheduled for 4:30 p.m. ET.

How can I access Schrödinger's Q3 2022 financial results webcast?

The webcast for Schrödinger's Q3 2022 financial results can be accessed on the company's investor website under 'News & Events'.

What is Schrödinger's business focus?

Schrödinger focuses on the discovery of therapeutics and materials using a physics-based computational platform.

How many employees does Schrödinger have?

Schrödinger has over 700 employees.

Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Stock Data

1.51B
62.15M
2.39%
96.24%
12.22%
Health Information Services
Pharmaceutical Preparations
Link
United States of America
NEW YORK